miR-155 Overexpression in OT-1 CD8

CD8+ T cells TCR antigen affinity adoptive cell transfer microRNA-155 oncoimmunology therapeutic vaccine

Journal

Molecular therapy oncolytics
ISSN: 2372-7705
Titre abrégé: Mol Ther Oncolytics
Pays: United States
ID NLM: 101666776

Informations de publication

Date de publication:
27 Mar 2020
Historique:
received: 03 12 2019
accepted: 16 12 2019
entrez: 6 2 2020
pubmed: 6 2 2020
medline: 6 2 2020
Statut: epublish

Résumé

Therapy by adoptive transfer of

Identifiants

pubmed: 32021906
doi: 10.1016/j.omto.2019.12.008
pii: S2372-7705(19)30110-X
pmc: PMC6994712
doi:

Types de publication

Journal Article

Langues

eng

Pagination

111-123

Informations de copyright

© 2019.

Références

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):476-81
pubmed: 25548153
J Biol Chem. 2007 Aug 17;282(33):23799-810
pubmed: 17540778
J Transl Med. 2011 Apr 20;9:44
pubmed: 21507256
Cell. 2015 Sep 10;162(6):1217-28
pubmed: 26321681
Blood. 2012 May 3;119(18):4133-41
pubmed: 22354001
J Virol. 2013 Feb;87(4):2348-51
pubmed: 23221547
Front Immunol. 2017 Dec 06;8:1696
pubmed: 29358931
J Clin Invest. 2015 May;125(5):2090-108
pubmed: 25893604
Blood. 2009 Aug 13;114(7):1374-82
pubmed: 19520806
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
J Clin Invest. 2013 Mar;123(3):1044-56
pubmed: 23391724
Curr Opin Genet Dev. 2002 Apr;12(2):225-32
pubmed: 11893497
N Engl J Med. 2011 Aug 25;365(8):725-33
pubmed: 21830940
Nature. 2006 Dec 7;444(7120):724-9
pubmed: 17086201
Blood. 2011 Apr 21;117(16):4293-303
pubmed: 21355095
Immunity. 2013 Apr 18;38(4):742-53
pubmed: 23601686
Immunity. 2003 Feb;18(2):255-64
pubmed: 12594952
J Biol Chem. 2017 Nov 10;292(45):18530-18541
pubmed: 28912267
Nature. 2009 Mar 12;458(7235):211-4
pubmed: 19182777
J Immunother Cancer. 2018 Sep 25;6(1):92
pubmed: 30253808
Nat Immunol. 2016 Jan;17(1):95-103
pubmed: 26523864
Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2735-40
pubmed: 19193853
J Clin Invest. 2010 Oct;120(10):3722-34
pubmed: 20890046
J Immunother Cancer. 2013 Dec 16;1:21
pubmed: 24829757
Science. 2007 Apr 27;316(5824):608-11
pubmed: 17463290
J Clin Invest. 2019 Feb 25;129(4):1551-1565
pubmed: 30694219
Immunity. 2014 Jun 19;40(6):865-79
pubmed: 24856900
Mol Cell Proteomics. 2007 Jun;6(6):1073-87
pubmed: 17351151
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15804-9
pubmed: 20720163
Nucleic Acids Res. 2009 Sep;37(17):5784-92
pubmed: 19596814
Cancer Immunol Res. 2019 Jun;7(6):1013-1024
pubmed: 31043416
Immunity. 2009 Jan 16;30(1):80-91
pubmed: 19144316
PLoS One. 2016 Jul 22;11(7):e0159724
pubmed: 27447824
Eur J Immunol. 2010 Jan;40(1):225-31
pubmed: 19877012
Nat Rev Mol Cell Biol. 2008 Jul;9(7):574-82
pubmed: 18523436
Blood. 2012 Apr 12;119(15):3478-85
pubmed: 22378844
Gene. 2001 Aug 22;274(1-2):157-67
pubmed: 11675008
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1969-74
pubmed: 14762166
Clin Cancer Res. 2011 Jul 1;17(13):4550-7
pubmed: 21498393
J Exp Med. 1992 Apr 1;175(4):1013-25
pubmed: 1532412
J Exp Med. 2003 Aug 18;198(4):569-80
pubmed: 12925674
Nat Immunol. 2013 Oct;14(10):1064-72
pubmed: 23955661
J Immunol. 1999 Jun 1;162(11):6351-8
pubmed: 10352247
J Exp Med. 2007 Oct 29;204(11):2667-77
pubmed: 17954566
Nat Immunol. 2013 Jun;14(6):593-602
pubmed: 23603793
Immunity. 2010 Oct 29;33(4):607-19
pubmed: 20888269
Cell Rep. 2018 May 15;23(7):2142-2156
pubmed: 29768211
J Theor Biol. 2007 Nov 21;249(2):395-408
pubmed: 17869274
J Immunol. 2015 Nov 15;195(10):4632-40
pubmed: 26447227
J Immunol. 2016 Mar 15;196(6):2838-46
pubmed: 26864034
J Immunol. 2018 Jul 15;201(2):792-803
pubmed: 29875150
Nat Med. 2013 Apr;19(4):473-80
pubmed: 23524343
Immunology. 2007 Oct;122(2):167-78
pubmed: 17484768
Cell Immunol. 2002 May-Jun;217(1-2):78-86
pubmed: 12426003
Cell Mol Immunol. 2009 Oct;6(5):343-52
pubmed: 19887047

Auteurs

Gwennaëlle C Monnot (GC)

Department of Fundamental Oncology and Ludwig Cancer Center, Faculty of Biology and Medicine, University of Lausanne, 1066 Epalinges, Switzerland.

Amaia Martinez-Usatorre (A)

Department of Fundamental Oncology and Ludwig Cancer Center, Faculty of Biology and Medicine, University of Lausanne, 1066 Epalinges, Switzerland.

Evripidis Lanitis (E)

Ludwig Institute for Cancer Research, Lausanne Branch at the University of Lausanne, 1066 Epalinges, Switzerland.

Silvia Ferreira Lopes (SF)

Department of Fundamental Oncology and Ludwig Cancer Center, Faculty of Biology and Medicine, University of Lausanne, 1066 Epalinges, Switzerland.

Wan-Chen Cheng (WC)

Department of Fundamental Oncology and Ludwig Cancer Center, Faculty of Biology and Medicine, University of Lausanne, 1066 Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch at the University of Lausanne, 1066 Epalinges, Switzerland.

Ping-Chih Ho (PC)

Department of Fundamental Oncology and Ludwig Cancer Center, Faculty of Biology and Medicine, University of Lausanne, 1066 Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch at the University of Lausanne, 1066 Epalinges, Switzerland.

Melita Irving (M)

Department of Fundamental Oncology and Ludwig Cancer Center, Faculty of Biology and Medicine, University of Lausanne, 1066 Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch at the University of Lausanne, 1066 Epalinges, Switzerland.

George Coukos (G)

Department of Fundamental Oncology and Ludwig Cancer Center, Faculty of Biology and Medicine, University of Lausanne, 1066 Epalinges, Switzerland.
Ludwig Institute for Cancer Research, Lausanne Branch at the University of Lausanne, 1066 Epalinges, Switzerland.

Alena Donda (A)

Department of Fundamental Oncology and Ludwig Cancer Center, Faculty of Biology and Medicine, University of Lausanne, 1066 Epalinges, Switzerland.

Pedro Romero (P)

Department of Fundamental Oncology and Ludwig Cancer Center, Faculty of Biology and Medicine, University of Lausanne, 1066 Epalinges, Switzerland.

Classifications MeSH